A single-center, randomized, parallel design study to evaluate the efficacy of donepezil in improving visuospatial abilities in patients with mild cognitive impairment using eye-tracker: the COG-EYE study protocol for a phase II trial
This study is designed to determine whether eye-tracking metrics can detect the effect of donepezil on visuospatial dysfunction more sensitively in patients with MCI. It is expected that multimodal data, such as eye-tracking and digital pen data, may provide helpful biomarkers for identifying subtle changes that are difficult to measure using conventional methods.Trial registrationClinical Research Information Service, Republic of Korea (CRIS, cris.nih.go.kr) KCT0006236. Registered on June 10, 2021. (Source: Trials)
Source: Trials - September 27, 2022 Category: Research Source Type: clinical trials
Publication of Adlarity Clinical Trial Data: Drug Exposure Equivalent to Oral Donepezil With Favorable GI Side Effect Profile
BOSTON, Sept. 19, 2022. Corium, Inc., a fully-integrated biopharmaceutical company leading the development and commercialization of novel central nervous system (CNS) therapies, announced publication of its phase 1 healthy volunteer study results... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - September 19, 2022 Category: Pharmaceuticals Source Type: clinical trials
Donepezil Prevents Urinary Retention After Extensive Total Hysterectomy
Condition: Urinary Retention After Procedure Interventions: Drug: Donepezil; Other: Usual care Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 15, 2022 Category: Research Source Type: clinical trials
